Pharma & Biopharma

Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry

New chemistry-free, light-based chromatography method offers gentler – and more efficient – route to protein purification

In the fourth installment of our series, our experts offer advice for navigating the regulatory pitfalls associated with nitrosamines

Three industry leaders each highlight an analytical frontier they believe is set to transform the future of the pharma and biopharma industries

Our experts return to offer their top tips for building a method from scratch for nitrosamine analysis

In terms of speed and robustness, mass spectrometry has inarguably made significant progress. But is the data we’re generating too much to handle?

Sample preparation, limits of detection, and structural determination – our experts return to discuss the analytical challenges with nitrosamines

Reflecting on current trends in analytical science; Deirdre Cabooter discusses AI, personalized medicine and the resurgence of green chemistry

In the first part of a new pharma-focused series, five experts share their first experiences with nitrosamines, as well as the dangers they pose

Supercritical fluid chromatography, PFAS analysis and more on day two!